NCT06904066
- Conditions
- Blood Cancer, Blood Protein Disorders, Bone Marrow Diseases, +42 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,101 public trials
583 recruiting studies
Hemostatic Disorders trial results
NCT01676805
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of the West Indies Kingston, Jamaica
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328
- Conditions
- B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus Aurora, Colorado, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Yale University School of Medicine - Yale Cancer Center New Haven, Connecticut, United States
NCT07637578
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
- Locations
-
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States
- SCRI Oncology Partners Nashville, Tennessee, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
NCT06049290
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT06262789
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Angers University hospital Angers, France
- Brest University Hospital, Morvan Site Brest, France
- Caen University hospital Caen, France
- Rennes University Hospital, Pontchaillou site Rennes, France
NCT05583617
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Prince of Wales Hospital Randwick, New South Wales, Australia
- St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
- CHU Lyon Sud - Service Hématologie Pierre-Bénite, France
- IUCT Oncopole Toulouse, France
NCT05927571
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Calvary Mater Newcastle Waratah, New South Wales, Australia
- Royal Adelaide Hospital;Haematology Clinical Trials Unit Adelaide, South Australia, Australia
- St. Vincent's Hospital Melbourne Melbourne, Victoria, Australia
NCT06822972
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Duke University Health System Durham, North Carolina, United States
Recruiting
Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma
NCT05208307
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States